Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial. (2022)
Attributed to:
A randomized controlled trial of influenza vaccine to prevent adverse vascular events.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00432-6
PubMed Identifier: 36400089
Publication URI: http://europepmc.org/abstract/MED/36400089
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Global health
Issue: 12
ISSN: 2214-109X